脑部放疗,上午比下午敏感许多!8 o8 j2 F) ~. U0 F3 j, r: Y
& j, }' ~! E! \; a# R
; ?* \, `% f! z8 t- P2 ]Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.: I8 w% F, b. U+ L. V0 }& }4 |
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?" Z; ~" r& K( `$ K& P' H: \( u
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
" g- f) S: Z: i( R% ~! oSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.4 N/ o0 G3 [) M+ a
1 S9 ?1 h+ a. @* k$ ~% u+ B
Abstract$ p# E7 Q' F, j* O p, O1 w
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
1 X0 }7 C0 A' a
' c* } C; v2 S3 H0 TMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.8 |2 l9 y* |* A. U5 H! X
8 M( c3 c% x Y) ^; u4 U, s/ H& E' DRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).% |! f( o, u4 ]
, n. W: Z* k5 m! Q7 H, f: Y
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
( i. j+ M7 T0 w8 G) w+ z
! G+ Y1 w/ d( d) z7 D9 Z( t/ } |